This press conference presented the results of an analysis of roughly 21 million COVID-19 vaccine recipients’ records, which the Japanese civic group “United Citizens for Stopping mRNA Vaccines” obtained from municipalities across the country via information disclosure requests (Japan’s FOIA, the Freedom of Information Act).
The event was attended by domestic and international experts, including Professor Emeritus Yasufumi Murakami of the Tokyo University of Science.

🟥 Introduction of Participants and Summary of Remarks

1. Ms. Masako Ganaha
Role & Introduction:
・Moderator of this press conference.
・Member of the civic group “United Citizens for Stopping mRNA Vaccines.”
Summary of Remarks:
・Explained that the purpose of the conference is to “share Japan’s data with the world in English, because it is attracting global attention.” [1:50]
・Emphasized that this data collection and analysis was made possible by the cooperation of over 300 volunteers. [0:59]
・Revealed that her organization, which campaigns about the dangers of replicon vaccines, has been under such pressure that it even received a warning letter from a major pharmaceutical company. [34:07]

2. Professor Yasufumi Murakami
Role & Introduction:
・Professor Emeritus at Tokyo University of Science.
・Responsible for the scientific analysis of this database and delivered the presentation.
Summary of Remarks:
・Highlighted that the most significant finding is a mortality peak not immediately after vaccination but approximately 120 days (about four months) later, as shown by the data. [20:06]
・Pointed out that this “time lag” may have caused many vaccine-related deaths to be overlooked. [22:33]
・Proposed hypotheses for the delayed mortality peak, including “immune suppression followed by autoimmune attack” and “toxicity from accumulated spike protein.” [27:08, 28:28]
・Reported a trend that the interval from vaccination to death shortens with each additional dose. [24:40]

3. Mr. Hama
Role & Introduction:
・Secretariat of the “United Citizens for Stopping mRNA Vaccines.”
・Presented an overview of the database and explained how it was developed.
Summary of Remarks:
・Explained that the database was constructed through information‐disclosure requests to municipalities nationwide and the cooperation of volunteers. [7:38]
・Stated that its purpose is to visualize the real health harms caused by the vaccines and to urge the government to review its policies. [37:11]
・Introduced the website’s functionality, noting that anyone can search by lot number and other criteria. [38:48]

4. Mr. Mike Adams
Role & Introduction:
・Special commentator.
・Founder of the renowned American science sites Brighteon and Natural News, and a globally recognized researcher.
Summary of Remarks:
・Praised the data analysis as “brilliant.” [42:04]
・Stated that the mortality distribution data demonstrates a clear causal relationship between the vaccine and deaths. [42:18]
・Asked, “Is there a correlation between cause of death and timing of death?” expressing anticipation for deeper analysis. [43:10]

5. Mr. Willem Engle
Role & Introduction:
・Special commentator.
・A prominent human rights activist in Europe.
Summary of Remarks:
・Pointed out that this data corroborates the notion that mRNA vaccines are akin to “gene therapy.” [46:42]
・Analyzed that the mortality peak at 120 days suggests spike-protein accumulation and the onset of autoimmune disorders. [48:00]
・Proposed that future research should also examine the relationship between these data and declining birth rates. [1:00:27]

6. Mr. Kenji Fujikawa
Role & Introduction:
・Commentator.
・Member of the Koganei City Council in Tokyo; former national research scientist and data‐analysis specialist.
Summary of Remarks:
・Introduced himself by explaining that he resigned his position as a national researcher to underscore the importance of this issue and is now serving as a city councilor. [1:18:46]
・Emphasized that his group was among the first in the world to sound the alarm about DNA contamination in vaccines. [1:19:48]
・Noted that the current data remain insufficient and revealed that he is pursuing more detailed analyses. [1:16:48]

7. Mr. Izumi Kamijo
Role & Introduction:
・Served as the interpreter from Japanese to English.
Summary of Remarks:
・Played a crucial role in accurately conveying Professor Murakami’s and other Japanese speakers’ statements to the international audience and fellow commentators. Thanks to his contributions, the cross-border discussion proceeded smoothly.

🟥 Main Findings of the Analysis
From this vast dataset, several critical facts have come to light.

Point 1: The mortality peak did not occur “immediately after

vaccination.”The most startling discovery is that the peak in deaths after vaccination did not appear right away, but roughly 120 days (3–4 months) later [5:44, 20:06]. Researchers had initially expected a mortality peak immediately following vaccination, but the data revealed a completely different pattern [15:43].

Why is this important?
Because a significant amount of time elapses after vaccination, many deaths may not be attributed to the vaccine and thus have likely been “overlooked” [20:51, 22:33]. This may be one reason why officially reported vaccine-related fatalities remain low.

Point 2: Significant Variation in Mortality Rates by Vaccine Lot

It was confirmed that mortality rates vary dramatically depending on the manufacturing lot of the vaccine administered. [8:45] Similar disparities had been noted in overseas studies—such as those from Denmark—but this large-scale Japanese dataset of roughly 21 million records also demonstrates the same trend. [8:50] This shows that not all vaccine lots carried the same level of risk.

Point 3: Shortened Interval to Death with Repeated Doses

Analysis of the data revealed a trend wherein the time from vaccination to death tends to shorten with each additional dose. [24:40]

Why Does It Take So Long Until Death? Professor Emeritus Murakami’s Hypotheses

Professor Emeritus Murakami proposed two possible explanations for the delayed mortality peak:

1. Impact of Immune Suppression
When an mRNA vaccine is administered, a large amount of spike protein is produced in the body. At this time, the immune system may become temporarily suppressed [26:52, 27:08]. Later, as spike protein production wanes, the previously suppressed immune system may rebound and begin attacking the body’s own cells [28:28].

2. Toxicity from Spike Protein Accumulation
Spike proteins produced in the body may not be rapidly broken down but instead gradually accumulate, inflicting damage and potentially leading to death several months later [16:03].

Association with Excess Mortality

Based on calculations using U.S. VAERS data and scaled to Japan’s population, it is estimated that roughly 610,000 deaths may have occurred following vaccination. [13:22] This figure is comparable to the number of “excess deaths” reported in Japan. [14:04]

At the press conference, it was noted that officially reported vaccine-related deaths account for only a small fraction, and that this 120-day mortality peak could explain many of the unreported fatalities. [14:04, 22:33]

🟥 About This Initiative

This database was compiled with the cooperation of approximately 350 Japanese volunteers. [0:59] The civic group uses this analysis to highlight the dangers of the vaccine and is calling on the government to suspend vaccinations. [30:16] The database is published on a website and is freely accessible to anyone. [35:21]

🟥 Slide Materials (Professor Yasufumi Murakami)